Ronald Limon MD, MSc

CLINICAL ONCOLOGIST#OncoBolivia#ClinicaDeLasAmericas

[Ronald Limon MD, MSc @RonaldLimonMD]

Advanced Breast Cancer in Latin America:
Evaluation, adaptation and implementation of the fifth consensus guidelines on advanced breast cancer (ABC5)
#JCOGO @JCOGO_ASCO
🔗:https://t.co/4YpxYphDYV

[Ronald Limon MD, MSc @RonaldLimonMD]

#SABCS23
#MadeinBolivia
#Clínica de Las Américas
#OncoBolivia
🇧🇴 🇵🇪 🇺🇸
Author: Ronald Sergio Limón Téllez
Title: TRIPTORELIN 11.25 MG vs TRIPTORELIN 3.75 MG IN PREMENOPAUSAL WOMEN WITH HIGH-RISK EARLY STAGE BREAST CANCER HR+) AND HER2(-). REAL WORLD EXPERIENCE. TRIPTO3STUDY.

[Ronald Limon MD, MSc @RonaldLimonMD]

Review
Myeloid-derived suppressor cells (MDSCs): what do we currently know about the effect they have against anti-PD-1/PD-L1 therapies?
https://t.co/tkK1gkdC55
@ecancer_espanol @ReynoldsLucia